Insulet

Ticker: PODD

Sector: Health Care Equipment & Supplies

Insulet

Insulet Corp. said on Tuesday Wayde McMillan would step down as the medical device makers chief financial officer, effective Oct. 3. Insulets accounting chief, Lauren Budden, will assume the additional responsibilities of interim CFO until a permanent successor is appointed. Insulet Corporation (PODD) stock has fallen -4.45% while the S&P 500 has gained 0.25% as of 9:37 AM on Wednesday, Oct 4. Wayde McMillan decided to leave his role as EVP, CFO and treasurer in March 2019. 3M spinoff picks Insulets Wayde McMillan as CFO. 3M CFO Wayde worked for Medtronic. Insulet (PODD) stock will have to gain more than 100% from here. Returning to the pre-inflation shock level of $318 means that PODD stock will need to gain over 100%. Insulets stock price is down 4.23% on the Nasdaq as of Thursday morning, coming in at $145.64 per share. Insulet reaffirmed its previously announced Omnipod revenues and total revenue guidance. Insulet Corporation (PODD) - 8-K - Current report SEC Filings: Insulets announced today that CFO departs for same post at 3Ms Health Care spinoff. Insulet Corporation, headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions.